Filter posts

Clinical Trial Success Rates - Recent Study from Tufts

Joseph DiMasi and his team at Tufts University published a paper earlier this year in …

IPO Update - November 11th, 2010

Today’s IPO from Complete Genomics (GNOM) brings the US biotech IPO list to 17 since …

State of the Industry - From BIO Investor Forum 2010

Here is our slide deck from the 9th annual BIO Investor Forum in San Francisco: …

IPO update: 28 IPOs, 24 on Deck

The number of IPOs slowed during the summer, but the queue has been filling nicely.  …

1Q Cash Spending - Small Biotechs Still Spending Less

A comparison of cash spent on operations in the 1st quarter of 2010 vs the …

1Q 2010 - All Time High for the BTK

The first quarter of 2010 saw the Amex Biotech Index (BTK) hit another all time …

FOPO - A Late Stage Financing Tool

The follow-on public offering (FOPO) market has been strong for biotech since early last year, …

Is P/E Compression Making Biotech a Bargin?

For the first time in biotech history, price to earnings multiples (P/E based on next …

Posts from the 9th Annual BIO Winhover & Pharmaceutical Strategic Outlook Conference (Feb 2010)

Did you miss a panel at the BIO Windhover/PSO Conference in New York? Here are …

BTK – A Decade of Change

Do you ever wonder what is really behind the often quoted BTK index (“NYSE Arca …